Filing Details

Accession Number:
0001209191-21-071561
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-29 20:41:43
Reporting Period:
2021-12-28
Accepted Time:
2021-12-29 20:41:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879407 Arrowhead Pharmaceuticals Inc. ARWR Pharmaceutical Preparations (2834) 460408024
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1506045 Mauro Ferrari 177 E. Colorado Blvd
Suite 700
Pasadena CA 91105
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-28 3,400 $66.82 36,571 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale was made to generate proceeds to cover the tax liability incident to an upcoming vesting of restricted stock units in January 2022.
  2. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.